Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE2E1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PTGR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CNOT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAD51AP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRAPPC6B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP1R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTPAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UFL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCLRE1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMBL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRPF39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STRBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on